Categories: Business

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) – Artificial intelligence has sped up early-stage drug development work at some of the world's largest

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

SNAPSHOT-India stocks, rupee, swaps, call at close

Nov 20 (Reuters) - STOCKS: The benchmark BSE Sensex was up 1.08% at 83,919.71, while…

56 seconds ago

Saliba fit for Arsenal's Newcastle trip, Zubimendi out with injured hamstring

VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM ARSENAL'S MANAGER MIKEL ARTETA AHEAD OF FACING NEWCASTLE UNITED…

2 minutes ago

Alphabet aims to raise $4.19 billion in Canadian debt offering

Nov 20 (Reuters) - Alphabet plans to raise C$6 billion ($4.19 billion) through a multi-tranche…

5 minutes ago

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial…

6 minutes ago

BRIEF-HG Gets Sales Commitments For Over 85% Of Jacktel Shares

Nov 20 (Reuters) - Hunter Group ASA: * UPDATE ON RECOMMENDED CASH PURCHASE ORDER FOR…

9 minutes ago